Franco Locatelli, Michael Jordan, Didier Halimi, Elena Burillo, Brian Jamieson, Emmanuel Monnet, Andrew Danquah. "Use of emapalumab is associated with rapid and sustained benefits in primary HLH subgroups, including CNS involvement and previously untreated patients: Pooled analysis of prospective trials NI-0501-04, NI-0501-05 and NI-0501-09." Blood, 2025. doi:10.1182/blood-2025-2979